Cargando…

Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review

With the progressive lengthening of the average age of the population, especially in some countries such as Italy, vaccination of the elderly is a fixed point on which most of the public health efforts are concentrating as epidemic infectious diseases, especially those of the winter, have a major im...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciarambino, Tiziana, Crispino, Pietro, Buono, Pietro, Giordano, Vincenzo, Trama, Ugo, Iodice, Vincenzo, Leoncini, Laura, Giordano, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537287/
https://www.ncbi.nlm.nih.gov/pubmed/37766089
http://dx.doi.org/10.3390/vaccines11091412
_version_ 1785113067212767232
author Ciarambino, Tiziana
Crispino, Pietro
Buono, Pietro
Giordano, Vincenzo
Trama, Ugo
Iodice, Vincenzo
Leoncini, Laura
Giordano, Mauro
author_facet Ciarambino, Tiziana
Crispino, Pietro
Buono, Pietro
Giordano, Vincenzo
Trama, Ugo
Iodice, Vincenzo
Leoncini, Laura
Giordano, Mauro
author_sort Ciarambino, Tiziana
collection PubMed
description With the progressive lengthening of the average age of the population, especially in some countries such as Italy, vaccination of the elderly is a fixed point on which most of the public health efforts are concentrating as epidemic infectious diseases, especially those of the winter, have a major impact on the progression of severe disease, hospitalization, and death. The protection of the elderly against acute infectious diseases should not only limit mortality but also have a positive impact on the fragility of these people in terms of less disability and fewer care needs. However, vaccination of the elderly population differs in efficacy and safety compared to that of other population categories since aging and the consequent loss of efficiency of the immune system lead to a reduction in the immunogenicity of vaccines without achieving a lasting antibody coverage. There are various strategies to avoid the failure of immunization by vaccines such as resorting to supplementary doses with adjuvant vaccines, increasing the dosage of the antigen used, or choosing to inoculate the serum relying on various routes of administration of the vaccine. Vaccination in the elderly is also an important factor in light of growing antibiotic resistance because it can indirectly contribute to combating antibiotic resistance, reducing theoretically the use of those agents. Furthermore, vaccination in old age reduces mortality from infectious diseases preventable with vaccines and reduces the same rate of resistance to antibiotics. Given the importance and complexity of the topic, in this review, we will deal with the main aspects of vaccination in the elderly and how it can influence mortality and healthcare costs, especially in those countries where population aging is more evident. Therefore, we conducted a systematic literature search in PubMed to identify all types of studies published up to 31 May 2023 that examined the association between vaccination and the elderly. Data extraction and quality assessment were conducted by two reviewers (PC and TC) who independently extracted the following data and assessed the quality of each study.
format Online
Article
Text
id pubmed-10537287
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105372872023-09-29 Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review Ciarambino, Tiziana Crispino, Pietro Buono, Pietro Giordano, Vincenzo Trama, Ugo Iodice, Vincenzo Leoncini, Laura Giordano, Mauro Vaccines (Basel) Review With the progressive lengthening of the average age of the population, especially in some countries such as Italy, vaccination of the elderly is a fixed point on which most of the public health efforts are concentrating as epidemic infectious diseases, especially those of the winter, have a major impact on the progression of severe disease, hospitalization, and death. The protection of the elderly against acute infectious diseases should not only limit mortality but also have a positive impact on the fragility of these people in terms of less disability and fewer care needs. However, vaccination of the elderly population differs in efficacy and safety compared to that of other population categories since aging and the consequent loss of efficiency of the immune system lead to a reduction in the immunogenicity of vaccines without achieving a lasting antibody coverage. There are various strategies to avoid the failure of immunization by vaccines such as resorting to supplementary doses with adjuvant vaccines, increasing the dosage of the antigen used, or choosing to inoculate the serum relying on various routes of administration of the vaccine. Vaccination in the elderly is also an important factor in light of growing antibiotic resistance because it can indirectly contribute to combating antibiotic resistance, reducing theoretically the use of those agents. Furthermore, vaccination in old age reduces mortality from infectious diseases preventable with vaccines and reduces the same rate of resistance to antibiotics. Given the importance and complexity of the topic, in this review, we will deal with the main aspects of vaccination in the elderly and how it can influence mortality and healthcare costs, especially in those countries where population aging is more evident. Therefore, we conducted a systematic literature search in PubMed to identify all types of studies published up to 31 May 2023 that examined the association between vaccination and the elderly. Data extraction and quality assessment were conducted by two reviewers (PC and TC) who independently extracted the following data and assessed the quality of each study. MDPI 2023-08-24 /pmc/articles/PMC10537287/ /pubmed/37766089 http://dx.doi.org/10.3390/vaccines11091412 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ciarambino, Tiziana
Crispino, Pietro
Buono, Pietro
Giordano, Vincenzo
Trama, Ugo
Iodice, Vincenzo
Leoncini, Laura
Giordano, Mauro
Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review
title Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review
title_full Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review
title_fullStr Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review
title_full_unstemmed Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review
title_short Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review
title_sort efficacy and safety of vaccinations in geriatric patients: a literature review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537287/
https://www.ncbi.nlm.nih.gov/pubmed/37766089
http://dx.doi.org/10.3390/vaccines11091412
work_keys_str_mv AT ciarambinotiziana efficacyandsafetyofvaccinationsingeriatricpatientsaliteraturereview
AT crispinopietro efficacyandsafetyofvaccinationsingeriatricpatientsaliteraturereview
AT buonopietro efficacyandsafetyofvaccinationsingeriatricpatientsaliteraturereview
AT giordanovincenzo efficacyandsafetyofvaccinationsingeriatricpatientsaliteraturereview
AT tramaugo efficacyandsafetyofvaccinationsingeriatricpatientsaliteraturereview
AT iodicevincenzo efficacyandsafetyofvaccinationsingeriatricpatientsaliteraturereview
AT leoncinilaura efficacyandsafetyofvaccinationsingeriatricpatientsaliteraturereview
AT giordanomauro efficacyandsafetyofvaccinationsingeriatricpatientsaliteraturereview